JP6920062B2 - 子宮内膜病変における幹細胞治療 - Google Patents

子宮内膜病変における幹細胞治療 Download PDF

Info

Publication number
JP6920062B2
JP6920062B2 JP2016573587A JP2016573587A JP6920062B2 JP 6920062 B2 JP6920062 B2 JP 6920062B2 JP 2016573587 A JP2016573587 A JP 2016573587A JP 2016573587 A JP2016573587 A JP 2016573587A JP 6920062 B2 JP6920062 B2 JP 6920062B2
Authority
JP
Japan
Prior art keywords
endometrial
bmdsc
subject
composition
autologous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2016573587A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017522288A (ja
JP2017522288A5 (enExample
Inventor
カルロス シモン，
カルロス シモン，
ハビエル サンタマリア，
ハビエル サンタマリア，
アントニオ ペイセール，
アントニオ ペイセール，
イレネ セルベジョ，
イレネ セルベジョ，
Original Assignee
アイジェノミクス エセ．エレ．
アイジェノミクス エセ．エレ．
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アイジェノミクス エセ．エレ．, アイジェノミクス エセ．エレ． filed Critical アイジェノミクス エセ．エレ．
Publication of JP2017522288A publication Critical patent/JP2017522288A/ja
Publication of JP2017522288A5 publication Critical patent/JP2017522288A5/ja
Application granted granted Critical
Publication of JP6920062B2 publication Critical patent/JP6920062B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2320/00—Applications; Uses
    • C12N2320/30—Special therapeutic applications

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Developmental Biology & Embryology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Thermotherapy And Cooling Therapy Devices (AREA)
JP2016573587A 2014-06-17 2015-06-05 子宮内膜病変における幹細胞治療 Active JP6920062B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462013121P 2014-06-17 2014-06-17
US62/013,121 2014-06-17
PCT/IB2015/001715 WO2015193737A1 (en) 2014-06-17 2015-06-05 Stem cell therapy in endometrial pathologies

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020102340A Division JP2020138984A (ja) 2014-06-17 2020-06-12 子宮内膜病変における幹細胞治療

Publications (3)

Publication Number Publication Date
JP2017522288A JP2017522288A (ja) 2017-08-10
JP2017522288A5 JP2017522288A5 (enExample) 2018-07-12
JP6920062B2 true JP6920062B2 (ja) 2021-08-18

Family

ID=54329860

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016573587A Active JP6920062B2 (ja) 2014-06-17 2015-06-05 子宮内膜病変における幹細胞治療
JP2020102340A Pending JP2020138984A (ja) 2014-06-17 2020-06-12 子宮内膜病変における幹細胞治療

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2020102340A Pending JP2020138984A (ja) 2014-06-17 2020-06-12 子宮内膜病変における幹細胞治療

Country Status (22)

Country Link
US (1) US11129851B2 (enExample)
EP (3) EP3158057B1 (enExample)
JP (2) JP6920062B2 (enExample)
CN (2) CN116747241A (enExample)
AU (1) AU2015275798B2 (enExample)
BR (1) BR112016029558A2 (enExample)
CA (1) CA2952559C (enExample)
CY (2) CY1122615T1 (enExample)
DK (2) DK3158057T3 (enExample)
ES (3) ES2983444T3 (enExample)
HR (3) HRP20240798T1 (enExample)
HU (3) HUE058328T2 (enExample)
LT (2) LT3158057T (enExample)
MX (1) MX377300B (enExample)
PL (3) PL3158057T3 (enExample)
PT (2) PT3158057T (enExample)
RS (3) RS63093B1 (enExample)
RU (1) RU2725006C2 (enExample)
SI (2) SI3158057T1 (enExample)
SM (3) SMT202400270T1 (enExample)
TR (1) TR201910410T4 (enExample)
WO (1) WO2015193737A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010010201A1 (es) 2008-07-22 2010-01-28 Equipo Ivi Investigacion Sl Perfil de expresion genetica como marcador de la receptividad endometrial
KR102226219B1 (ko) 2012-06-06 2021-03-10 펀다시오 인스티튜트 드 르세르카 바이오메디카 (아이알비 바르셀로나) 폐암 전이의 진단, 예후 및 치료 방법
JP6074049B2 (ja) 2012-10-12 2017-02-01 インバイオモーション エセ．エレ． ｃ−ＭＡＦを用いた前立腺がん転移の診断、予後診断および処置のための方法
US10119171B2 (en) 2012-10-12 2018-11-06 Inbiomotion S.L. Method for the diagnosis, prognosis and treatment of prostate cancer metastasis
US20140314792A1 (en) 2013-03-15 2014-10-23 Institució Catalana De Recerca I Estudis Avançats Method for the diagnosis, prognosis and treatment of cancer metastasis
HUE058328T2 (hu) 2014-06-17 2022-07-28 Asherman Therapy S L Õssejtterápia endometriális patológiás állapotokban
AU2017281631B2 (en) * 2016-06-23 2023-06-15 Tithon Biotech, Inc. Cells expressing parathyroid hormone 1 receptor and uses thereof
RU2699029C1 (ru) * 2018-12-10 2019-09-03 Частное образовательное учреждение дополнительного профессионального образования "Академия медицинского образования имени Федора Ивановича Иноземцева" (ЧОУ ДПО "Академия медицинского образования им. Ф.И. Иноземцева") Способ использования мезенхимальных стволовых клеток для улучшения состояния рубца на матке
RU2741621C1 (ru) * 2020-09-25 2021-01-28 Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр акушерства, гинекологии и перинатологии имени академика В.И. Кулакова" Министерства здравоохранения Российской Федерации Способ лечения внутриматочных синехий
CN117979980A (zh) 2021-07-23 2024-05-03 车医科学大学校产学协力团 用于预防或治疗阿谢曼综合征的包含分离的线粒体作为活性成分的药物组合物

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990013299A1 (en) 1989-05-05 1990-11-15 Northern Sydney Area Health Service Fertility enhancement
US6979533B2 (en) 1992-06-12 2005-12-27 The Trustees Of The University Of Pennsylvania Determination of endometrial receptivity toward embryo implantation
CA2203718A1 (en) 1997-04-25 1998-10-25 University Of British Columbia Cadherin-11 as an indicator of viable pregnancy
IL127896A0 (en) 1998-12-31 1999-10-28 Gail Laster A novel treatment for preeclampsia and related diseases
AU2001240096A1 (en) 2000-03-08 2001-09-17 Rebecca L. Dubowy Methods of diagnosing and monitoring endometrial glandular development
JP2004504275A (ja) 2000-05-24 2004-02-12 シエーリング　アクチエンゲゼルシャフト フィブリン−１の医薬用途
US6780594B2 (en) 2000-09-25 2004-08-24 Schering Aktiengesellschaft Method for in vitro diagnosis of endometriosis
AUPR673001A0 (en) 2001-07-31 2001-08-23 Prince Henry's Institute Of Medical Research Pregnancy-related enzyme activity
DE10139874A1 (de) 2001-08-10 2003-04-30 Schering Ag Humane Mater-Proteine
GB0201284D0 (en) 2002-01-21 2002-03-06 Isis Innovation Screening methods for contraceptive and fertility agents
US20030186300A1 (en) 2002-03-20 2003-10-02 Ali Akoum Methods and products for modulation of reproductive processes and for diagnosis, prognostication and treatment of related conditions
EP1511863A4 (en) 2002-05-14 2006-12-27 Univ Leland Stanford Junior ENDOMETRIAL GENES FOR THE DETECTION OF ENDOMETRIAL DISORDERS
WO2004014935A1 (de) 2002-08-02 2004-02-19 Schering Aktiengesellschaft Progesteronrezeptormodulatoren mit erhöhter antigonadotroper aktivität für die weibliche fertilitätskontrolle und hormonersatztherapie
DE10236405A1 (de) 2002-08-02 2004-02-19 Schering Ag Progesteronrezeptormodulatoren mit erhöhter antigonadotroper Aktivität für die weibliche Fertilitätskontrolle und Hormonersatztherapie
EP1579007B1 (de) 2002-12-21 2015-05-27 Universität Leipzig Verfahren und mittel zur bestimmung von bestimmten zuständen bzw. veränderungen im uterusepithel und im epithel anderer organe
US20060286555A1 (en) 2003-08-21 2006-12-21 Van Beuningen Marinus G J Microarray support for bioprobe synthesis
CN1863905A (zh) 2003-09-08 2006-11-15 得克萨斯系统大学董事会 通过用前列腺素或前列腺素类似物补充培养基加强体外胚发育的方法以及组合物
WO2005026324A2 (en) 2003-09-08 2005-03-24 The Board Of Regents Of The University Of Texas System Method and composition for enhancing in vitro embryo development by supplementing culture medium with prostaglandin or a prostaglandin analog
US20080226554A1 (en) 2003-12-23 2008-09-18 Mount Sinai Hospital Methods For Detecting Markers Associated With Endometrial Disease or Phase
EP1765083A4 (en) 2004-05-28 2008-08-20 Serono Lab USE OF IL-17 TO TREAT FERTILITY DISORDERS
US20090111140A1 (en) * 2006-03-31 2009-04-30 Koninklijke Philips Electronics N.V. Systems and methods for cell measurement utilizing ultrashort t2*
JP2007278750A (ja) 2006-04-04 2007-10-25 Ono Pharmaceut Co Ltd プロスタグランジン類及びその類縁体の定量方法
US20120269774A1 (en) * 2006-09-21 2012-10-25 Medistem Laboratories, Inc Allogeneic stem cell transplants in non-conditioned recipients
GB0703683D0 (en) * 2007-02-26 2007-04-04 Ark Therapeutics Ltd The treatment of complications in pregnancy
US9259233B2 (en) * 2007-04-06 2016-02-16 Hologic, Inc. Method and device for distending a gynecological cavity
US8673850B2 (en) 2008-05-30 2014-03-18 Institut De Recherches Cliniques De Montreal PCSK9 inhibitors and methods of use thereof
WO2010010201A1 (es) 2008-07-22 2010-01-28 Equipo Ivi Investigacion Sl Perfil de expresion genetica como marcador de la receptividad endometrial
WO2013166281A1 (en) * 2012-05-02 2013-11-07 Cedars-Sinai Medical Center Bi-functional compositions for targeting cells to diseased tissues and methods of using same
EP2348318A1 (en) 2010-01-21 2011-07-27 Equipo Ivi Investigación, S.L. Diagnostic method for endometrial receptivity
EP2768976B1 (en) 2011-10-21 2018-01-10 Institut National de la Santé et de la Recherche Médicale (INSERM) Methods for assessing endometrial receptivity of a patient after controlled ovarian hyperstimulation
US9423402B2 (en) 2011-11-30 2016-08-23 Singapore Health Services Pte. Ltd. GM1 ganglioside to annexin V microparticle polypeptide ratio for biological monitoring
BR112014029233A8 (pt) 2012-06-27 2019-01-29 Hoffmann La Roche método para diagnosticar se um indivíduo grávido não está em risco, usos de pelo menos um dos biomarcadores sfit-1, endoglina e pigf, dispositivo, kit, método de gestão de um indivíduo, sistema e método para estabelecer um auxílio
RU2515475C1 (ru) * 2012-11-15 2014-05-10 Федеральное государственное бюджетное учреждение науки ИНСТИТУТ ЦИТОЛОГИИ РОССИЙСКОЙ АКАДЕМИИ НАУК Способ стимуляции образования децидуальной оболочки эндометрия в эксперименте
WO2015166353A2 (en) 2014-03-21 2015-11-05 Equipo I. V. I. Investigacion S.L. Early detection of preeclampsia
HUE058328T2 (hu) 2014-06-17 2022-07-28 Asherman Therapy S L Õssejtterápia endometriális patológiás állapotokban

Also Published As

Publication number Publication date
US11129851B2 (en) 2021-09-28
MX2016016756A (es) 2017-11-02
US20170128492A1 (en) 2017-05-11
PT3569697T (pt) 2022-05-02
HRP20220419T1 (hr) 2022-05-27
CA2952559A1 (en) 2015-12-23
SMT202400270T1 (it) 2024-07-09
EP3158057B1 (en) 2019-04-17
JP2020138984A (ja) 2020-09-03
EP4012023C0 (en) 2024-05-15
RS59210B1 (sr) 2019-10-31
PL3158057T3 (pl) 2020-05-18
ES2910306T3 (es) 2022-05-12
RU2017101147A (ru) 2018-07-17
CY1125938T1 (el) 2024-02-16
JP2017522288A (ja) 2017-08-10
SMT202200155T1 (it) 2022-05-12
LT3569697T (lt) 2022-04-25
HUE044823T2 (hu) 2019-11-28
PT3158057T (pt) 2019-07-19
RS65719B1 (sr) 2024-08-30
EP4012023A1 (en) 2022-06-15
WO2015193737A1 (en) 2015-12-23
AU2015275798A1 (en) 2017-02-02
EP4012023B1 (en) 2024-05-15
MX377300B (es) 2025-03-07
LT3158057T (lt) 2019-09-25
EP3569697A1 (en) 2019-11-20
EP3569697B8 (en) 2022-04-27
AU2015275798B2 (en) 2021-03-25
RS63093B1 (sr) 2022-04-29
HUE058328T2 (hu) 2022-07-28
HRP20191240T1 (hr) 2019-11-01
SI3158057T1 (sl) 2019-10-30
SI3569697T1 (sl) 2022-05-31
RU2725006C2 (ru) 2020-06-29
DK3569697T3 (da) 2022-04-04
CA2952559C (en) 2023-01-24
HRP20240798T1 (hr) 2024-09-27
CN107073040A (zh) 2017-08-18
DK3158057T3 (da) 2019-07-29
CN116747241A (zh) 2023-09-15
CY1122615T1 (el) 2021-03-12
TR201910410T4 (tr) 2019-08-21
RU2017101147A3 (enExample) 2019-02-06
ES2983444T3 (es) 2024-10-23
SMT201900400T1 (it) 2019-09-09
PL3569697T3 (pl) 2022-07-04
BR112016029558A2 (pt) 2017-08-22
HUE067463T2 (hu) 2024-10-28
ES2736117T3 (es) 2019-12-26
EP3158057A1 (en) 2017-04-26
EP3569697B1 (en) 2022-01-05
PL4012023T3 (pl) 2024-09-02

Similar Documents

Publication Publication Date Title
JP6920062B2 (ja) 子宮内膜病変における幹細胞治療
Gao et al. Uterine artery embolization followed by dilation and curettage within 24 hours compared with systemic methotrexate for cesarean scar pregnancy
Puente Gonzalo et al. Intrauterine infusion of platelet-rich plasma for severe Asherman syndrome: a cutting-edge approach
Hu et al. Cyclical endometrial repair and regeneration: molecular mechanisms, diseases, and therapeutic interventions
US12350292B2 (en) Bioactive renal cells for the treatment of chronic kidney disease
CN112870228B (zh) 一种多功能微环境保护外泌体水凝胶及其制备方法和应用
de Miguel‐Gómez et al. Strategies for managing Asherman's syndrome and endometrial atrophy: since the classical experimental models to the new bioengineering approach
Spinelli et al. Endoscopic repair of a vesicouterine fistula with the injection of microfragmented autologous adipose tissue (Lipogems®)
HK40075844B (en) Stem cell therapy in endometrial pathologies
HK40075844A (en) Stem cell therapy in endometrial pathologies
HK40099394A (zh) 子宫内膜病理状况中的干细胞治疗
HK1242600A1 (en) Stem cell therapy in endometrial pathologies
Lassiter et al. MP52-07 EXTENDED PHARMACOLOGICAL THROMBOPROPHYLAXIS POST ROBOTIC PROSTATECTOMY WITH PELVIC LYMPH NODE DISSECTION
Amer et al. Organic Tissue Grafts Following Intrauterine Adhesiolysis
Wang et al. MP52-06 IMMEDIATE RADICAL PROSTATECTOMY AFTER INTRAOPERATIVE CONFIRMED DIAGNOSIS OF PROSTATE CANCER BY FROZEN SECTION OF SPECIMEN FROM TARGETED BIOPSY-INVESTIGATION OF A NOVEL STRATEGY
Delis AMD3100 Administration for the Treatment of Asherman’s Syndrome in a Murine Model
Dige et al. of Injection
Peng et al. Preventive Management of Hypertriglycer-idemia in Pregnancy
Sampietro et al. A retrospective comparison of Calistar A versus the second-generation light-weight Calistar S for treating anterior and apical pelvic organ prolapse
Balci et al. The treatment of Cesarean Scar Pregnancies with Foley Catheter Application following Suction Curettage
Maegawa et al. A case of placental polyp treated with an intraoperative injection of prostaglandin F2α followed by hysteroscopic resection
Pfeifer et al. Gut Online First, published on October 29, 2009 as 10.1136/gut. 2009.181347

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170613

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180604

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20180604

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20190604

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20190902

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20191101

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20200213

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200612

C60 Trial request (containing other claim documents, opposition documents)

Free format text: JAPANESE INTERMEDIATE CODE: C60

Effective date: 20200612

C11 Written invitation by the commissioner to file amendments

Free format text: JAPANESE INTERMEDIATE CODE: C11

Effective date: 20200624

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20200709

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20200806

C21 Notice of transfer of a case for reconsideration by examiners before appeal proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C21

Effective date: 20200807

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20201016

C211 Notice of termination of reconsideration by examiners before appeal proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C211

Effective date: 20201020

C22 Notice of designation (change) of administrative judge

Free format text: JAPANESE INTERMEDIATE CODE: C22

Effective date: 20210325

C22 Notice of designation (change) of administrative judge

Free format text: JAPANESE INTERMEDIATE CODE: C22

Effective date: 20210407

C23 Notice of termination of proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C23

Effective date: 20210528

C03 Trial/appeal decision taken

Free format text: JAPANESE INTERMEDIATE CODE: C03

Effective date: 20210624

C30A Notification sent

Free format text: JAPANESE INTERMEDIATE CODE: C3012

Effective date: 20210624

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20210726

R150 Certificate of patent or registration of utility model

Ref document number: 6920062

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

S533 Written request for registration of change of name

Free format text: JAPANESE INTERMEDIATE CODE: R313533

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250